Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The rise of the ethical license

The Broad Institute's recent licensing of its gene editing patent portfolio demonstrates how licenses can be used to restrict controversial applications of emerging technologies while society deliberates their implications.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Rood, J. The Scientist http://www.thescientist.com/?articles.view/articleNo/42595/title/Who-Owns-CRISPR-/ (3 April 2015).

    Google Scholar 

  2. The Broad Institute, Inc. v. The Regents of the Univ. of California. Declaration of Interference No. 106,048 (2016).

  3. Sherkow, J.S. Nat. Biotechnol. 33, 256–257 (2015).

    Article  CAS  Google Scholar 

  4. Han, A.P. GenomeWeb https://www.genomeweb.com/gene-silencinggene-editing/non-crispr-genome-editing-technologies-find-niche-biotech-applications (8 August 2016).

  5. Pollack, R. Science 348, 871 (2015).

    Article  CAS  Google Scholar 

  6. Abbasi, J. JAMA 316, 482–483 (2016)

    Article  Google Scholar 

  7. Baltimore, D. et al. Science 348, 36–38 (2015).

    Article  CAS  Google Scholar 

  8. Lanphier, E., Urnov, F., Haecker, S.E., Werner, M. & Smolenski, J. Nature 519, 410–411 (2015).

    Article  CAS  Google Scholar 

  9. Liang, P. et al. Protein Cell 6, 363–372 (2015).

    Article  CAS  Google Scholar 

  10. Kang, X. et al. J. Assist. Reprod. Genet. 33, 581–588 (2016).

    Article  Google Scholar 

  11. Olson, S. (ed.) International Summit on Human Gene Editing: a Global Discussion (National Academies Press, Washington, DC, 2016).

    Book  Google Scholar 

  12. Begley, S. STAT News https://www.statnews.com/2016/09/22/monsanto-licenses-crispr/ (22 September 2016).

  13. Editas Medicine, Inc. Securities and Exchange Commission Form S-1, amend. 1 (2016).

  14. Regalado, A. https://www.technologyreview.com/s/602633/stop-gene-spills-before-they-happen/ MIT Technol. Rev. (20 October 2016).

  15. Mimura, C. in Working within the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society (eds. Dreyfuss, R.C., First, H. & Zimmerman, D.L.) 269–295 (Oxford University Press, New York, 2010).

    Google Scholar 

  16. Rosen, I. https://www.broadinstitute.org/news/licensing-crispr-agriculture-policy-considerations Broad Institute News (29 September 2016).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christi J Guerrini.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Guerrini, C., Curnutte, M., Sherkow, J. et al. The rise of the ethical license. Nat Biotechnol 35, 22–24 (2017). https://doi.org/10.1038/nbt.3756

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3756

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing